Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$281K Buy
995
+2
+0.2% +$580 0.17% 42
2025
Q2
$277K Buy
993
+5
+0.5% +$1.42K 0.17% 38
2025
Q1
$308K Sell
988
-15
-1% -$4.43K 0.28% 30
2024
Q4
$261K Buy
1,003
+1
+0.1% +$297 0.21% 37
2024
Q3
$316K Hold
1,002
0.21% 36
2024
Q2
$326K Hold
1,002
0.24% 30
2024
Q1
$285K Hold
1,002
0.23% 35
2023
Q4
$289K Buy
+1,002
New +$273K 0.29% 32

Other funds holding AMGN

Gimbal Financial's AMGN Position: Q3 2025 in Review

Gimbal Financial increased its Amgen (AMGN) stake by 0.2% in Q3 2025, buying an estimated $580 and bringing the position to 995 shares worth $281K. The position accounts for 0.17% of the portfolio, ranked #42.

Gimbal Financial first reported a position in AMGN in Q4 2023 and has held it in 8 quarters since. The position peaked at $326K in Q2 2024. 2,820 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Gimbal Financial held 995 shares of Amgen worth $281K as of Q3 2025.
  • Gimbal Financial bought 2 Amgen shares in Q3 2025, an estimated $580.
  • Amgen made up 0.17% of Gimbal Financial's portfolio in Q3 2025, its #42 holding.
  • Gimbal Financial first reported a position in Amgen in Q4 2023 and has held it in 8 quarters since.
  • Gimbal Financial's Amgen position peaked at $326K in Q2 2024.
  • 2,820 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Gimbal Financial's 13F filing for Q3 2025, filed 4 Nov 2025.